Quercetin and hyperthermia modulate cisplatin-induced DNA damage in tumor and normal tissues in vivo

Tumor Biology

Volumn 35, Issue 7, 2014, Pages 6445-6454

  Oršolić, Nada ^a   Car, Nikola ^b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b PLIVA CROATIA LTD   (Croatia)

Author keywords

Chemotherapy; Cisplatin; DNA damage; Ehrlich ascites tumor; Hyperthermia; Immunomodulation; Quercetin

Indexed keywords

CISPLATIN; QUERCETIN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD CELL; CANCER CHEMOTHERAPY; CELL PROTECTION; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DRUG CYTOTOXICITY; DRUG EFFECT; EHRLICH ASCITES TUMOR CELL; HYPERTHERMIC THERAPY; IMMUNE RESPONSE; IMMUNOSTIMULATION; IN VIVO STUDY; KIDNEY CELL; LIVER CELL; MACROPHAGE; MALE; MOUSE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; TUMOR IMMUNITY;

ANIMALS; BLOOD CELLS; CARCINOMA, EHRLICH TUMOR; CELL LINE, TUMOR; CISPLATIN; DNA DAMAGE; HUMANS; HYPERTHERMIA, INDUCED; KIDNEY; LIVER; MICE; QUERCETIN;

EID: 84904957705     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1843-y     Document Type: Article

References (44)

1. Muthana M, Multhoff G, Pockley AG. Tumour infiltrating host cells and their significance for hyperthermia. Int J Hyperth. 2010;26(3):247-55.
2. Orsolić N, Bevanda M, Kujundzić N, Plazonic A, Stajcar D, Kujundzić M. Prevention of peritoneal carcinomatosis in mice by combining hyperthermal intraperitoneal chemotherapy with the water extract from Burr parsley (Caucalis platycarpos L.). Planta Med. 2010;76(8):773-9.
3. Bevanda M, Orsolic N, Basic I, Vukojevic K, Benkovic V, Horvat Knezevic A, et al. Prevention of peritoneal carcinomatosis in mice with combination hyperthermal intraperitoneal chemotherapy and IL-2. Int J Hyperth. 2009;2:132-40.
4. He B, Wang X, Shi HS, Xiao WJ, Zhang J, Mu B, et al. Quercetin liposome sensitizes colon carcinoma to thermotherapy and thermochemotherapy in mice models. Integr Cancer Ther. 2012;12(3):264-70.
5. Komarova LN, Petin VG, Saenko AS. The recovery parameters of DNA strand breaks of Ehrlich ascites cells after the combined action of ionizing radiation and hyperthermia. Radiats Biol Radioecol. 2007;47:584-90.
6. Gross C, Hansch D, Gatspar R, Multhoff G. Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94. Biol Chem. 2003;384:267-79. (Pubitemid 36348327)
7. Ito A, Tanaka K, Kondo K, Shinkai M, Honda H, Matsumoto K, et al. Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma. Cancer Sci. 2003;94:308-13. (Pubitemid 36575900)
8. Ivarsson K, Myllymaki L, Jansner K, Stenram U, Tranberg KG. Resistance to tumor challenge after tumor laser thermotherapy is associated with a cellular immune response. Br J Cancer. 2005;93:435-40. (Pubitemid 43080017)
9. Glockzin G, Schlitt HJ, Piso P. Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol. 2009;7:5.
10. de Bree E, Rosing H, Michalakis J, Romanos J, Relakis K, Theodoropoulos PA, et al. Intraperitoneal chemotherapy with taxanes for ovarian cancer with peritoneal dissemination. Eur J Surg Oncol. 2006;32:666-70. (Pubitemid 44087882)
11. Kartalou M, Essigmann JM. Recognition of cisplatin adducts by cellular proteins. Mutat Res. 2001;478:1-21. (Pubitemid 32530847)
12. Brozovic G, Orsolic N, Knezevic F, Horvat Knezevic A, Benkovic V, Sakic K, et al. Genotoxicity and cytotoxicity of cisplatin treatment combined with anaesthetics on EAT cells in vivo. Onkologie. 2009;6:337-43.
13. Oršolić N, Bevanda M, Bendelja K, Horvat- Knežević A, Benković V, Bašić I. Propolis and related polyphenolic compounds; their relevance on host resistance and interaction with chemotherapy. Scientific evidence of the use of propolis in ehtnomedicine. In: Oršolić N, Bašić I, editors. Ethnopharmacology - review book. Kerala: Transworld Research Network; 2008. p. 223-50.
14. Naziroglu M, Karaoǧlu A, Aksoy AO. Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. Toxicology. 2004;195:221-30. (Pubitemid 38125121)
15. Oršolić N, Horvat-Knežević A, Benković V, Bašić I. Benefits of use of propolis and related flavonoids against the toxicity of chemotherapeutic agents. Scientific evidence of the use of propolis in ehtnomedicine. In: Oršolić N, Bašić I, editors. Ethnopharmacology - review book. Kerala: Transworld Research Network; 2008. p. 195-22.
16. Atessahin A, Yilmaz S, Karahan I, Ceribasi AO, Karaoglu A. Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats. Toxicology. 2005;212:116-23. (Pubitemid 40981968)
17. Yousef MI, Saad AA, El-Shennawy LK. Protective effect of grape seed proanthocyanidin extract against oxidative stress induced by cisplatin in rats. Food Chem Toxicol. 2009;47:1176-83.
18. Yapar K, Çavuşoǧlu K, Oruç E, Yalçin E. Protective effect of royal jelly and green tea extracts effect against cisplatin-induced nephrotoxicity inmice: a comparative study. J Med Food. 2009;12:1136-42.
19. Iraz M, Ozerol E, Gulec M, Tasdemir S, Idiz N, Fadillioglu E, et al. Protective effect of caffeic acid phenethyl ester (CAPE) administration on cisplatin-induced oxidative damage to liver in rat. Cell Biochem Funct. 2006;24:357-61. (Pubitemid 44065240)
20. Benkovic V, Horvat Knezevic A, Dikic D, Lisicic D, Orsolic N, Basic I, et al. Radioprotective effects of propolis and quercetin gamma-irradiated mice evaluated by the alkaline comet assay. Phytomedicine. 2008;15:851-8.
21. Oršolić N, Benković V, Horvat-Knežević A, Kopjar N, Kosalec I, Bakmaz M, et al. Assessment by survival analysis of the radioprotective properties of propolis and its polyphenolic compounds. Biol Pharm Bull. 2007;30:946-51. (Pubitemid 46708646)
22. Moskaug JØ, Carlsen H, Myhrstad M, Blomhoff R. Molecular imaging of the biological effects of quercetin and quercetin-rich foods. Mech Ageing Dev. 2004;125:315-24. (Pubitemid 38438511)
23. Myhrstad MC, Carlsen H, Nordström O, Blomhoff R, Moskaug JØ. Flavonoids increase the intracellular glutathione level by transactivation of the gamma-glutamylcysteine synthetase catalytical subunit promoter. Free Radic Biol Med. 2002;32:386-93. (Pubitemid 34178348)
24. Yao P, Nussler A, Liu L, Hao L, Song F, Schirmeier A, et al. Quercetin protects human hepatocytes from ethanol-derived oxidative stress by inducing heme oxygenase-1 via the MAPK/Nrf2 pathways. J Hepatol. 2007;47:253-61. (Pubitemid 47023137)
25. Morales AI, Vicente-Sánchez C, Jerkic M, Santiago JM, Sánchez-González PD, Pérez-Barriocanal F, et al. Effect of quercetin on metallothionein, nitric oxide synthases and cyclooxygenase-2 expression on experimental chronic cadmium nephrotoxicity in rats. Toxicol Appl Pharmacol. 2006;210:128-35. (Pubitemid 41790560)
26. Oršolić N, Bašić I. Cancer chemoprevention by propolis and its polyphenolic compounds in experimental animals. In: Govil JN, Singh VK, Bhardwaj R, editors. Recent progress in medicinal plants, Volume 17: Phytochemistry and pharmacology III. Houston: Studium Press; 2007. p. 55-113.
27. Oršolić N, Benković V, Lisičić D, Erhard J, Horvat-Knežević A. Protective effects of propolis and related polyphenolic/flavonoid compounds against toxicity induced by irinotecan. Med Oncol. 2010;27:1346-58.
28. Sanchez-Gonzalez PD, Lopez-Hernandez FJ, Perez-Barriocanal F, Morales AI, Lopez-Novoa JM. Quercetin reduces cisplatin nephrotoxicity in rats without compromising its anti-tumor activity. Nephrol Dial Transplant. 2011;26:3484-95.
29. Orsolic N, Sirovina D, Krbavcic M, Car N. Effect of flavonoids and hyperthermal intraperitoneal chemotherapy on tumour growth and micronucleus induction in mouse tumour model. Hum Exp Toxicol. 2013 Aug 7.
30. Singh NP, McCoy MT, Tice RR, Schneider LL. A simple technique for quantitation of low levels od DNA damage in individual cells. Exp Cell Res. 1988;175:184-91.
31. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-65.
32. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-48.
33. Asanami S, Shimono K. The effect of hyperthermia on micronucleus induction by mutagens in mice. Mutat Res. 1999;446:149-54.
34. Kim JH, Kim SH, Alfieri AA, Young CW. Quercetin, an inhibitor of lactate transport and a hyperthermic sensitizer of HeLa cells. Cancer Res. 1984;44:102-6. (Pubitemid 14178068)
35. Sharma H, Sen S, Singh N. Molecular pathways in the chemosensitization of cisplatin by quercetin in human head and neck cancer. Cancer Biol Ther. 2005;4:949-55. (Pubitemid 41598589)
36. Roman J, Rangasamy T, Guo J, Sugunan S, Meednu N, Packirisamy G, et al. T-cell activation under hypoxic conditions enhances IFN-gamma secretion. Am J Respir Cell Mol Biol. 2010;42:123-8.
37. Schilling D, Gehrmann M, Steinem C, de Maio A, Pockley AG, Abend M, et al. Binding of heat shock protein 70 to extracellular phosphatidylserine promotes killing of normoxic and hypoxic tumor cells. FASEB J. 2009;23:2467-77.
38. Wang SY, Duan KM, Li Y, Mei Y, Sheng H, Liu H, et al. Effect of quercetin on P-glycoprotein transport ability in Chinese healthy subjects. Eur J Clin Nutr. 2013;67:390-4.
39. Gibalová L, Sereš M, Rusnák A, Ditte P, LabudováM, Uhrík B, et al. P-glycoprotein depresses cisplatin sensitivity in L1210 cells by inhibiting cisplatin-induced caspase-3 activation. Gen Physiol Biophys. 2009;28:391-403.
40. Yang L, Li N, Wang H, Jia X, Wang X, Luo J. Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance. Oncol Rep. 2012;28:592-600.
41. Ferry DR, Smith A, Malkhandi J, Fyfe DW, de Takats PG, Anderson D, et al. Phase I clinical trial of the avonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res. 1996;2:659-68. (Pubitemid 26133468)
42. Hofmann J, Fiebig HH, Winterhalter BR, Berger DP, Grunicke H. Enhancement of the antiproliferative activity of cis-diamminedichloroplatinum(II) by quercetin. Int J Cancer. 1990;45:536-9. (Pubitemid 20087205)
43. Pabla N, Dong Z. Curtailing side effects in chemotherapy: a tale of PKCδ in cisplatin treatment. Oncotarget. 2012;3:107-11.
44. Grunicke H, Hofmann J, Maly K, Uberall F, Posch L, Oberhuber H, et al. The phospholipid and calcium dependent protein kinase as a target in tumor chemotherapy. Adv Enzym Regul. 1989;28:201-10.